Mechanisms and management of cough in interstitial lung disease.

Expert review of respiratory medicine Pub Date : 2023-12-01 Epub Date: 2023-12-30 DOI:10.1080/17476348.2023.2299751
Ameer Z Rasheed, Mark L Metersky, Fatima Ghazal
{"title":"Mechanisms and management of cough in interstitial lung disease.","authors":"Ameer Z Rasheed, Mark L Metersky, Fatima Ghazal","doi":"10.1080/17476348.2023.2299751","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Many patients with interstitial lung diseases (ILDs), especially fibrotic ILDs, experience chronic cough. It negatively impacts both physical and psychological well-being. Effective treatment options are limited.</p><p><strong>Areas covered: </strong>The pathophysiology of chronic cough in IPF is complex and involves multiple mechanisms, including mechanical distortion of airways, parenchyma, and nerve fibers. The pathophysiology of cough in other fibrosing ILDs is poorly understood and involves various pathways. The purpose of this review is to highlight mechanisms of chronic cough and to present therapeutic evidence for its management in the most commonly occurring diffuse fibrosing lung diseases including idiopathic pulmonary fibrosis (IPF), connective tissue disease-related interstitial lung disease (CTD-ILD), sarcoidosis-related ILD (Sc-ILD), chronic hypersensitivity pneumonitis-related ILD (CHP-ILD), and post-COVID-19-related interstitial lung disease (PC-ILD).</p><p><strong>Expert opinion: </strong>This review guides the management of chronic cough in fibrosing ILDs. In this era of precision medicine, chronic cough management should be individualized in each interstitial lung disease.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"1177-1190"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17476348.2023.2299751","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Many patients with interstitial lung diseases (ILDs), especially fibrotic ILDs, experience chronic cough. It negatively impacts both physical and psychological well-being. Effective treatment options are limited.

Areas covered: The pathophysiology of chronic cough in IPF is complex and involves multiple mechanisms, including mechanical distortion of airways, parenchyma, and nerve fibers. The pathophysiology of cough in other fibrosing ILDs is poorly understood and involves various pathways. The purpose of this review is to highlight mechanisms of chronic cough and to present therapeutic evidence for its management in the most commonly occurring diffuse fibrosing lung diseases including idiopathic pulmonary fibrosis (IPF), connective tissue disease-related interstitial lung disease (CTD-ILD), sarcoidosis-related ILD (Sc-ILD), chronic hypersensitivity pneumonitis-related ILD (CHP-ILD), and post-COVID-19-related interstitial lung disease (PC-ILD).

Expert opinion: This review guides the management of chronic cough in fibrosing ILDs. In this era of precision medicine, chronic cough management should be individualized in each interstitial lung disease.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
间质性肺病咳嗽的机理和治疗。
导言:许多间质性肺病(ILDs)患者,尤其是纤维化间质性肺病患者,都有慢性咳嗽的经历。它对患者的身心健康都有负面影响。有效的治疗方案有限:IPF 慢性咳嗽的病理生理学非常复杂,涉及多种机制,包括气道、肺实质和神经纤维的机械变形。其他纤维化 ILD 咳嗽的病理生理学尚不十分清楚,涉及多种途径。本综述旨在强调慢性咳嗽的发病机制,并介绍治疗最常见的弥漫性纤维化肺部疾病(包括特发性肺纤维化(IPF)、结缔组织病相关性间质性肺病(CTD-ILD)、肉样瘤病相关性间质性肺病(Sc-ILD)、慢性超敏性肺炎相关性间质性肺病(CHP-ILD)和 COVID-19 后相关性间质性肺病(PC-ILD))的治疗证据:本综述为纤维化 ILD 中慢性咳嗽的治疗提供了指导。在这个精准医疗的时代,慢性咳嗽的治疗应针对每种间质性肺病进行个体化治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Acute respiratory failure in adult patients with acute myeloid leukemia. Measuring exhaled nitric oxide in COPD: from theoretical consideration to practical views. Is the nicotine metabolite ratio a useful tool to improve the effectiveness, safety, and adherence to quitting smoking? Systematic review of the literature and meta-analysis. An update on endobronchial valve therapy for severe emphysema: real world data and special indications. What is new in synthetic lung surfactant protein technology?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1